| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 1 | |||
| NCT07383233 | CD19/BAFF-R in Vivo CAR-T Cell Therapy Targeting Relapsed/Refractory B Cell Acute… | Lymphoma | Not Yet Recruiting |
| NCT07538713 | Functionally Optimized CD33 CAR-T Cell Therapy Targeting Recurrent/Refractory Acute… | CAR T Cell Therapy | Not Yet Recruiting |
| NCT07574073 | CD20 Monoclonal Antibody Combined With BTK Inhibitor for the Treatment of Refractory… | Anti-CD20 Monoclonal Antibody | Not Yet Recruiting |
| Early Phase 1 | |||
| NCT07365059 | Safety and Efficacy of GPRC5D CAR-T Cell Therapy in Relapsed/Refractory Plasma Cell… | Plasma Cell Dyscrasias | Not Yet Recruiting |
| Not specified | |||
| NCT07008872 | CD7 CAR-T Cell Therapy Targeting CD7-positive Relapsed/Refractory T Cell Lymphoma/Acute… | CD7+ Lymphoma | Not Yet Recruiting |